Healthcare Finance News December 14, 2023
HHS also released the names of the first 10 drugs under Part D selected for Medicare drug price negotiations.
Dozens of pharmaceutical companies will be required to pay rebates to Medicare for price hikes on prescription drugs that went against the mandate of the Inflation Reduction Act, the Biden Administration announced yesterday.
For the last quarter of 2023, 48 Medicare Part B drugs raised their prices faster than inflation, and some drug companies raised prices of certain medications faster than inflation for every quarter over the last year, according to The White House announcement.
These drugs may be subject to inflation rebates in the first quarter of 2024. Starting in January, some Medicare beneficiaries who take these 48 prescription drugs...
Today's Sponsors
Today's Sponsor